Trade Pluri Inc. - PLUR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1936 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.8482 |
| Open | 4.8482 |
| 1-Year Change | 408.36% |
| Day's Range | 4.8482 - 5.0682 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2024 | 5.0682 | 0.2200 | 4.54% | 4.8482 | 5.0682 | 4.8482 |
| Apr 23, 2024 | 4.8482 | -0.1000 | -2.02% | 4.9482 | 5.0082 | 4.8482 |
| Apr 19, 2024 | 5.1882 | 0.3900 | 8.13% | 4.7982 | 5.1882 | 4.7982 |
| Apr 18, 2024 | 4.9282 | -0.1100 | -2.18% | 5.0382 | 5.0382 | 4.9182 |
| Apr 17, 2024 | 5.2082 | -0.2000 | -3.70% | 5.4082 | 5.4082 | 4.6682 |
| Apr 16, 2024 | 5.4982 | -0.0700 | -1.26% | 5.5682 | 5.5682 | 5.4082 |
| Apr 15, 2024 | 5.6282 | 0.0000 | 0.00% | 5.6282 | 5.7082 | 5.6282 |
| Apr 12, 2024 | 5.4782 | 0.0600 | 1.11% | 5.4182 | 5.5082 | 5.4182 |
| Apr 11, 2024 | 5.9182 | 0.2400 | 4.23% | 5.6782 | 6.0282 | 5.4482 |
| Apr 10, 2024 | 6.0482 | 0.6800 | 12.67% | 5.3682 | 6.1782 | 5.3682 |
| Apr 9, 2024 | 5.6182 | 0.0900 | 1.63% | 5.5282 | 5.8382 | 5.4582 |
| Apr 8, 2024 | 5.4582 | -0.5000 | -8.39% | 5.9582 | 6.0582 | 5.2082 |
| Apr 5, 2024 | 5.3582 | 0.5500 | 11.44% | 4.8082 | 5.5282 | 4.7282 |
| Apr 4, 2024 | 4.9182 | -0.1000 | -1.99% | 5.0182 | 5.0382 | 4.5382 |
| Apr 3, 2024 | 5.2382 | -0.1700 | -3.14% | 5.4082 | 5.4082 | 4.9482 |
| Apr 2, 2024 | 5.5082 | 0.0000 | 0.00% | 5.5082 | 5.7482 | 5.3982 |
| Apr 1, 2024 | 5.8882 | -0.4718 | -7.42% | 6.3600 | 6.3600 | 5.4982 |
| Mar 28, 2024 | 0.7950 | -0.0548 | -6.45% | 0.8498 | 0.8498 | 0.7061 |
| Mar 27, 2024 | 0.8532 | -0.0414 | -4.63% | 0.8946 | 0.9642 | 0.8216 |
| Mar 26, 2024 | 1.0082 | 0.0637 | 6.74% | 0.9445 | 1.0182 | 0.9444 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Pluri Inc. Company profile
About Pluristem Therapeutics Inc.
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
Financial summary
BRIEF: For the six months ended 31 December 2021, Pluristem Therapeutics Inc. revenues was not reported. Net loss increased 6% to $22.4M. Higher net loss reflects General and administrative expenses increase of 30% to $4.8M (expense), Stock-based Compensation in SGA increase of 9% to $4.6M (expense), Research & Development Expense decrease of 75% to $72K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to -$0.70.
Equity composition
Common Stock $0.00001 Par, 01/13, 100M auth., 58,333,206 issd. Insiders control 11.74%. IPO: NA. 11/07,1-for-200 reverse stock split. 11/07, Name changed from Pluristem Life Systems, Inc. 12/07, Exchanged changed from OTC Bulletin Board to NASDAQ.
| Industry: | Biotechnology & Medical Research (NEC) |
Matam Park Building 5
HAIFA
3508409
IL
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com